Dilution of existing shareholders through the exercise of stock acquisition rights
First written in FY2021. 8 of 18 entries say "Materialised", first in FY2022-Q3. Latest entry: FY2027-H1.
Appirits moved to the "Worse" side of this theme in 2021, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
0 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「14th Series of Stock Acquisition Rights pursuant to a resolution of the Board of Directors dated 27 May 2026 Number of stock acquisition rights: 100 Common shares: 10,000」
Regarding the previously disclosed 14th Series of Stock Acquisition Rights, the company states that 100 rights covering 10,000 shares were issued to 1 director of a subsidiary. It also states that some of the existing 10th Series A, 11th Series and 12th Series of Stock Acquisition Rights had expired. - 2026-05-27WorsenedShare Issuance and Disposal
「Subsidiary director 1 person 100 rights」
For the 14th series of stock acquisition rights, the allocation of 100 rights to 1 subsidiary director, representing a total of 10,000 shares, has been specified. As the rights have not yet been exercised, dilution remains potential. - FY2026MitigatedAnnual report
「As of the end of January 2026, the number of potential shares represented by stock acquisition rights was 406,300, equivalent to 9.7% of the 4,196,562 issued shares.」
The number of potential shares and their ratio to the total number of issued shares decreased from the previous disclosure of 464,300 shares and 11.2%, respectively. Meanwhile, an issuance limit for Series 14 stock acquisition rights was established after the filing. - FY2026-H1WorsenedAnnual report
「Number of stock acquisition rights: 540; class, description and number of shares underlying the stock acquisition rights: 54,000 common shares」
As Series 13 stock acquisition rights, rights covering 54,000 shares were issued to directors, department heads and directors of subsidiaries, adding potential dilution exposure. - FY2025MaterialisedAnnual report
「As of the end of January 2025, the number of potential shares represented by stock acquisition rights was 464,300, equivalent to 11.2% of the 4,158,762 issued shares. If these stock acquisition rights representing potential shares are exercised, new shares of the Company will be issued, potentially diluting the value of shares held by existing shareholders and their voting rights.」
The Company disclosed 464,300 potential shares represented by stock acquisition rights, equivalent to 11.2% of the total number of issued shares. In addition, the number of shares increased by 32,100 through the exercise of stock acquisition rights during the fiscal year. - FY2025-H1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights on 15 May 2024 increased the number of shares by 2,100, with dilution taking place in practice. - FY2025-Q1WorsenedAnnual report
「At a meeting of the Board of Directors held on 17 May 2024, the Company resolved to issue stock acquisition rights as stock options to its directors, excluding outside directors, executive officers, department heads and directors of subsidiaries, and issued them on 1 June 2024. (5) Class and number of shares underlying the stock acquisition rights: Common shares, 139,000 shares」
Stock acquisition rights covering 139,000 shares were issued to directors, executive officers, department heads and directors of subsidiaries, increasing potential dilution exposure. - FY2024MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 93,000 between 2 May 2023 and 22 January 2024, and increased share capital and the capital reserve by ¥18.962 million each. - FY2024-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 16,500 shares, with dilution of existing shareholders taking place in practice. - FY2024-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 17,700 between 1 May and 31 July 2023, indicating that dilution was taking place in practice. - FY2024-Q1WorsenedAnnual report
「60,000 common shares」
The 60,000 shares underlying stock acquisition rights issued on 1 June 2023 were added, increasing potential dilution exposure. - FY2023-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 19,500 between 1 August and 31 October 2022, and increased share capital and the capital reserve by ¥3.925 million each. Dilution was taking place in practice. - FY2023-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 87,300 between 1 May and 31 July 2022, indicating that dilution was taking place in practice. - FY2023-Q1WorsenedAnnual report
「Number of stock acquisition rights: 704」
On 1 June 2022, stock acquisition rights covering 70,400 common shares were issued, adding potential dilution exposure. - FY2022-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in an increase of 4,500 issued shares between 1 August and 31 October 2021, as well as increases of ¥900 thousand each in share capital and the capital reserve. - FY2021First statedAnnual report
「As of 31 January 2021, the number of potential shares represented by stock acquisition rights was 214,200, equivalent to 20.0% of the 1,071,100 issued shares. If these stock acquisition rights representing potential shares are exercised, new shares of the Company will be issued, potentially diluting the value of shares held by existing shareholders and their voting rights.」
The Company discloses the number of potential shares and its ratio to the total number of issued shares.